Latest AI and machine learning research in skin cancer for healthcare professionals.
Selecting clinically relevant tumor antigens remains a major challenge in the development of therape...
Ovarian cancer remains a major cause of gynecologic cancer mortality; and, although immune checkpoin...
Gastric cancer (GC) remains a major global health burden and is frequently diagnosed at advanced sta...
Chronic inflammation is a universally acknowledged characteristic of cancer, playing the role of a v...
Despite a decade in, immunotherapy (IO) treatment selection in non-small cell lung cancer (NSCLC) re...
BACKGROUND: Enfortumab vedotin (EV) therapy for advanced urothelial carcinoma is limited by adverse ...
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies. Ter...
BACKGROUND: Malignant melanoma (MM) is an emerging public health concern in East Asia's rapidly agin...
Cancer immunotherapy has revolutionized the treatment landscape, yet its clinical efficacy is limite...
Cellular senescence (CS) exerts dual roles in tumorigenesis, yet its pan-cancer molecular characteri...
Pancreatic ductal adenocarcinoma (PDA) is profoundly immunosuppressive. To help define this behavior...
Pancreatic adenocarcinoma (PAAD) is an immunosuppressive malignancy refractory to radiotherapy and i...
Breast cancer, particularly hormone receptor-positive (HR+) and triple-negative (TNBC) subtypes, is ...
BACKGROUND: Patient-derived organoids (PDOs) provide physiologically relevant 3D tumor models for pr...
Artificial intelligence (AI) has become a pivotal driver of innovation in cancer immunotherapy throu...
BACKGROUND: Preoperative stratification for non-small cell lung cancer (NSCLC) necessitates separate...
AIMS: To develop and validate a deep learning framework for discriminating BRAF mutation status in c...
Choroidal melanoma is the most common primary intraocular malignancy in adults, and its evaluation r...
Immunotherapy has transformed the management of genitourinary cancers, offering durable responses in...
Non-small-cell lung cancer (NSCLC) remains the leading cause of cancer death worldwide, and clinicia...
This study developed a Prognostic and Immunotherapeutic Signature (PIS) for NSCLC using single-cell ...